Behcet's disease associated with bone marrow failure in Korean patients: Clinical characteristics and the association of intestinal ulceration and trisomy 8

Rheumatology

Volumn 47, Issue 8, 2008, Pages 1228-1230

  Ahn, J K ^a   Cha, Hook Suk ^a   Koh, E M ^a   Kim, S H ^a   Kim, Y G ^b   Lee, C K ^b   Yoo, B ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Aplastic anaemia; Behcets disease; Intestinal ulceration; Myelodysplastic syndrome; Trisomy 8

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BEHCET DISEASE; BONE MARROW DEPRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE INJURY; INTESTINE ULCER; KOREA; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TRISOMY 8;

ADULT; ANEMIA, APLASTIC; BEHCET SYNDROME; BONE MARROW DISEASES; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; TRISOMY; ULCER;

EID: 47849111313     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken162     Document Type: Article

References (19)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-91.
2. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Behcet's disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 2006;24:S115-9.
3. Kawabata H, Sawaki T, Kawanami T et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: Significance of trisomy 8. Intern Med 2006;45:1309-14.
4. Young NS. Harrison's internal medicine, 16th edition. New York: McGraw-Hill, 2005;617-26.
5. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG. Myelodysplasia-associated autoimmunity: Clinical and pathophysiologic concepts. Eur J Clin Invest 2004;34:690-700.
6. Criteria for diagnosis of Behcet's disease. International study group for Behcet's disease. Lancet 1990;335:1078-80.
7. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-302.
8. Hsu HC, Lee YM, Tsai WH et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 2002;63:64-9.
9. Sfikakis PP, Markomichelakis N, Alpsoy E et al. Anti-TNF therapy in the management of Behcet's disease - review and basis for recommendations. Rheumatology 2007;46:736-41.
10. Raza A, Candoni A, Khan U et al. Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma 2004;45:2099-104.
11. Barnes CG, Yazici H. Behcet's syndrome. Rheumatology 1999;38:1171-4.
12. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behcet's disease: An analysis of 2147 patients. Yonsei Med J 1997;38:423-7.
13. Arnold JA, Ranson SA, Abdalla SH. Azathioprine-associated acute myeloid leukaemia with trillneage dysplasia and complex karyotype: A case report and review of the literature. Clin Lab Haematol 1999;21:289-92.
14. Sole F, Prieto F, Badia L et al. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 1992;64:12-20.
15. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002;99:3129-35.
16. Chen G, Zang W, Miyazato A et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 2004;104:4210-8.
17. Zeng W, Chen G, Kajigaya S et al. Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and heafthy volunteers. Blood 2004;103:325-32.
18. Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006;79:439-48.
19. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thromposis - Behcet's syndrome. Leuk Lymphoma 2001;42:115-21.